CALC

CalciMedica (CALC)

About CalciMedica (CALC)

CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Details

Daily high
$0.66
Daily low
$0.58
Price at open
$0.59
52 Week High
$7.20
52 Week Low
$0.52
Market cap
8.6M
Dividend yield
0.00%
Volume
569,426
Avg. volume
3.2M
P/E ratio
-.37

CalciMedica News

Details

Daily high
$0.66
Daily low
$0.58
Price at open
$0.59
52 Week High
$7.20
52 Week Low
$0.52
Market cap
8.6M
Dividend yield
0.00%
Volume
569,426
Avg. volume
3.2M
P/E ratio
-.37